de Jonge Gabriela, Dos Santos Talita L, Cruz Bruno R, Simionatto Mackelly, Bittencourt Jeanine I M, Krum Everson A, Moss Mariane F, Borato Danielle Cristyane K
Department of Clinical and Toxicological Analysis, State University of Ponta Grossa-UEPG, Ponta Grossa, Brazil.
J Clin Lab Anal. 2018 Jun;32(5):e22396. doi: 10.1002/jcla.22396. Epub 2018 Feb 3.
Hemolysis may occur in vivo, under pathological conditions, or in vitro, related to pre-analytical errors. Hemolyzed samples may produce unreliable results, leading to errors in diagnostic and monitoring evaluations. This study aims to evaluate the interference of in vitro hemolysis on the interpretation of the parameters of the blood cell-counting performed by the impedance method.
Peripheral blood samples were collected in anticoagulant K2-EDTA and subsequently divided into three 1.0 mL aliquots. The first aliquot was not subjected to any intervention, and the second and third aliquots were passed 5 and 10 times through a small-gauge needle to produce scalar amounts of hemolysis. Hematological tests were performed by Hemacounter 60-RT 7600 .
Comparison of the samples with different degrees of hemolysis showed a decrease in red blood cells count and hematocrit counts and increase in mean corpuscular hemoglobin concentration and platelet count in samples with a high degree of hemolysis. According to the accepted clinical point of view, the samples with a high degree of hemolysis exceeded the desirable bias, presenting decrease in red blood cells count, hematocrit and mean corpuscular volume, and increase in red cell distribution width, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, and platelet counts. However, samples with a mild degree of hemolysis showed only a slight increase in mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, and platelet count.
This study demonstrated that in vitro hemolysis can decrease the clinical and analytical reliability of the assessment of the blood count.
溶血可能在体内、病理条件下发生,也可能在体外因分析前误差而出现。溶血样本可能产生不可靠的结果,导致诊断和监测评估出现错误。本研究旨在评估体外溶血对阻抗法进行血细胞计数参数解读的干扰。
采集外周血样本,置于K2-EDTA抗凝剂中,随后分成三个1.0 mL的等分试样。第一等分试样不进行任何干预,第二和第三等分试样通过小口径针头分别穿刺5次和10次,以产生不同程度的溶血。使用Hemacounter 60-RT 7600进行血液学检测。
不同程度溶血样本的比较显示,高度溶血样本的红细胞计数和血细胞比容降低,平均红细胞血红蛋白浓度和血小板计数增加。根据公认的临床观点,高度溶血样本超出了可接受的偏差范围,表现为红细胞计数、血细胞比容和平均红细胞体积降低,红细胞分布宽度、平均红细胞血红蛋白、平均红细胞血红蛋白浓度和血小板计数增加。然而,轻度溶血样本仅表现出平均红细胞血红蛋白、平均红细胞血红蛋白浓度和血小板计数略有增加。
本研究表明,体外溶血会降低血细胞计数评估的临床和分析可靠性。